|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| MarketWatch: Biotechnology |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Mai 2006 |
Taille du document : |
37 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Bioinformatics IR
pages | Juillet 2001 |
There is little doubt that biology is going large-scale.
Great leaps in high throughput technologies fueled by the genome sequencing projects, gene expression analysis and proteomics, to name but a |
1 600,00 €
|
| |
| |
Carbohydrate Therapeutics
180 pages | Décembre 2000 |
Carbohydrates are the only class of biological molecule (there are four main classes: nucleic acids, proteins, lipids, and carbohydrates - commonly known as sugars), that can be found in direct associ |
1 400,00 €
|
| |
| |
03-010: The Market for Toxicogenomics Products & Services
193 pages | Avril 2003 |
This report provides a look at service providers, informatics products, microarrays and databases from the end-user's perspective |
640,00 €
|
| |
| |
DNA Sequencing and PCR Markets
252 pages | Novembre 2004 |
The focus of this report is to describe the specific segment of the life sciences market called DNA sequencing.
This analysis includes all of the generally accepted DNA-oriented analytical activiti |
2 800,00 €
|
| |
| |
Pharmacogenomics IRCD
pages | Juillet 2001 |
The Human Genome Project and numerous corporate and academic human gene sequencing efforts have revealed, among others, that genes exist in the population in numerous mutated forms, some of which are |
1 200,00 €
|
| |
| |
Arthritis Drug Discovery IRCD
pages | Juin 2001 |
Arthritis (from the Greek for joint) is a chronic multi-factorial disease of the joints, induced when the immune system attacks and begins degrading the joints.
The disease knows no racial boun |
1 026,17 €
|
| |
| |
03-054: Immunohistochemistry Market Benchmarking Survey
90 pages | Octobre 2003 |
This report provides an overview of the most commonly used methods and products for tissue/sample preparation and antigen detection to help suppliers understand researchers’ experiences, preferences a |
680,00 €
|
| |
| |
The Diagnostics Outlook to 2005
130 pages | Février 1999 |
Diagnostic market : The current in vitro diagnostic (IVD) market is discussed, identifying how the market can be segmented according to country, end user, clinical speciality and disease area.
795,00 €
|
|
| |
| |
Target and Lead Validation
160 pages | Décembre 2000 |
The advent of brute force approaches to lead generation has highlighted a key bottleneck in drug development.
The issue is not how many new compounds can one make per day, but rather how many c |
1 400,00 €
|
| |
| |
Biopharmaceutical Industry in China, 2004
110 pages | Octobre 2004 |
|
830,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| MarketWatch: Biotechnology |
|
|
Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.
|
|
Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.
|
|
|
PPLSEN
|
|
|
|
|
